Dr Ryohei Ono
- Sponsored Researcher (Cardiovascular & Metabolic Health)
- Visiting Research Fellow (School of Cardiovascular & Metabolic Health)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Ono, R. et al. (2026) Lactate dehydrogenase and outcomes in patients with HF and reduced ejection fraction. JACC: Heart Failure, (doi: 10.1016/j.jchf.2025.102900) (In Press)
Chimura, M. et al. (2025) Serum magnesium and outcomes in heart failure with reduced ejection fraction: the GALACTIC-HF trial. European Heart Journal, (doi: 10.1093/eurheartj/ehaf706) (PMID:40886161) (Early Online Publication)
Ono, R. et al. (2026) Lactate dehydrogenase and outcomes in patients with HF and reduced ejection fraction. JACC: Heart Failure, (doi: 10.1016/j.jchf.2025.102900) (In Press)
Chimura, M. et al. (2025) Serum magnesium and outcomes in heart failure with reduced ejection fraction: the GALACTIC-HF trial. European Heart Journal, (doi: 10.1093/eurheartj/ehaf706) (PMID:40886161) (Early Online Publication)